Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging

Kidney International

Volumn 73, Issue 6, 2008, Pages 778-781

  Wallace, D P ^a,c   Hou, Y P ^a   Huang, Z L ^a   Nivens, E ^a   Savinkova, L ^a   Yamaguchi, T ^a   Bilgen, M ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

ADPKD; Cystic kidney; Kidney volume; Progression of renal failure; Renal pathology

Indexed keywords

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMAGE ANALYSIS; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 40049105387     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002771     Document Type: Article

References (13)

1. L.P. Sullivan D.P. Wallace J.J. Grantham Chloride and fluid secretion in polycystic kidney disease J Am Soc Nephrol 9 1998 903 916
2. J.J. Grantham V.E. Torres A.B. Chapman Volume progression in polycystic kidney disease N Engl J Med 354 2006 2122 2130
3. Y. Sun J. Zhou C. Stayner Magnetic resonance imaging assessment of a murine model of recessive polycystic kidney disease Comp Med 52 2002 433 438
4. B. Fei C. Flask H. Wang Image segmentation, registration and visualization of serial MR images for therapeutic assessment of polycystic kidney disease in transgenic mice Conf Proc IEEE Eng Med Biol Soc 1 2005 467 469
5. H. Olbrich M. Fliegauf J. Hoefele Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis Nat Genet 34 2003 455 459
6. H. Takahashi J.P. Calvet D. Dittemore-Hoover A hereditary model of slowly progressive polycystic kidney disease in the mouse J Am Soc Nephrol 1 1991 980 989
7. V.H. Gattone II X. Wang P.C. Harris Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist Nat Med 9 2003 1323 1326
8. S. Omori M. Hida H. Fujita Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease J Am Soc Nephrol 17 2006 1604 1614
9. V.H. Gattone II B.D. Cowley Jr B.D. Barash Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents Am J Kidney Dis 25 1995 302 313
10. P. Ruggenenti A. Remuzzi P. Ondei Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease Kidney Int 68 2005 206 216
11. Y. Tao J. Kim R.W. Schrier Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease J Am Soc Nephrol 16 2005 46 51
12. V.E. Torres Therapies to slow polycystic kidney disease Nephron Exp Nephrol 98 2004 e1 e7
13. B.S. Magenheimer P.L. St John K.S. Isom Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) co-transporter-dependent cystic dilation J Am Soc Nephrol 17 2006 3424 3437